Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo(NUVO) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (60)	1/7/2006 1:28:43 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 140

Always nice to see some free publicity for one of your favorite stocks and next week's Barron's highlights Nuvelo in their weekly feature...Charting the Market. This feature reflects the charts for 12 stocks each week that have shown great activity..both up and down! Anyway Nuvelo's chart is reflected with the following comment.." Nuvelo agreed to have Bayer AG bring its blood-clot-dissolving drug to market. Investors bid Nuvelo to a 52 week high, JAZZED by the $385 Million in milestone payments it could earn from the deal."

To: Arthur Radley who wrote (60)	1/7/2006 4:14:35 PM
From: dr.praveen	Respond to of 140

Hi TD, Thanks for your post and offering more insight into the deal. When i bought NUVO an year ago without doing much research, I felt Alf won't capture a huge market and the hospitals won't give much margin and I closed my position. I agree with you that's it is a very good deal for Nuvo. I want to consider reinvesting in Nuvo. What are your thoughts and predictions about the current market cap and the potential upside to the stock with ref to milestones from here? TIA, Dr.P